Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models

Microbial Pathogenesis

Volumn 42, Issue 4, 2007, Pages 138-147

  Li, Lulu ^a   Kashleva, Helena ^a   Dongari Bagtzoglou, Anna ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Candida glabrata; Cytokines; Cytotoxicity; Oral epithelium

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 8;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FUNGAL STRAIN; HUMAN; HUMAN CELL; MOUTH INFECTION; PATHOGENESIS; PRIORITY JOURNAL;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, ORAL; CELL LINE; CYTOKINES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; KERATINOCYTES; MOUTH MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 33947393261     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2006.12.003     Document Type: Article

References (39)

1. Fidel Jr. P.L., Vazquez J.A., and Sobel J.D. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12 (1999) 80-96
2. Vazquez J.A. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection. Pharmacotherapy 19 (1999) 76-87
3. Redding S.W., Zellars R.C., Kirkpatrick W.R., McAtee R.K., Caceres M.A., Fothergill A.W., et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37 (1999) 3896-3900
4. Redding S.W. The role of yeasts other than Candida albicans in oropharyngeal candidiasis. Curr Opin Infect Dis 14 (2001) 673-677
5. Redding S.W., Kirkpatrick W.R., Coco B.J., Sadkowski L., Fothergill A.W., Rinaldi M.G., et al. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol 40 (2002) 1879-1881
6. Dongari-Bagtzoglou A., and Fidel Jr. P.L. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J Dent Res 84 (2005) 966-977
7. Schaller M., Mailhammer R., Grassl G., Sander C.A., Hube B., and Korting H.C. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 118 (2002) 652-657
8. Dongari-Bagtzoglou A., and Kashleva H. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 34 (2003) 169-177
9. Dongari-Bagtzoglou A., Kashleva H., and Villar C.C. Bioactive interleukin-1alpha is cytolytically released from Candida albicans-infected oral epithelial cells. Med Mycol 2 (2004) 31-41
10. Dongari-Bagtzoglou A., Villar C.C., and Kashleva H. Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro. Med Mycol 43 (2005) 545-549
11. Dongari-Bagtzoglou A., and Kashleva H. Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol Immunol 18 (2003) 165-170
12. Villar C.C., Kashleva H., and Dongari-Bagtzoglou A. Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol Immunol 19 (2004) 262-269
13. Villar C.C., Kashleva H., Mitchell A.P., and Dongari-Bagtzoglou A. Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun 73 (2005) 4588-4595
14. Dongari-Bagtzoglou A., and Kashleva H. Development of a novel three-dimensional in vitro model of oral Candida infection. Microb Pathog 40 (2006) 271-278
15. Lockhart S.R., Joly S., Vargas K., Swails-Wenger J., Enger L., and Soll D.R. Natural defenses against Candida colonization breakdown in the oral cavities of the elderly. J Dent Res 78 (1999) 857-868
16. Bagg J., Sweeney M.P., Lewis M.A., Jackson M.S., Coleman D., Al M.A., et al. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 17 (2003) 477-481
17. Filler S.G., Pfunder A.S., Spellberg B.J., Spellberg J.P., and Edwards Jr. J.E. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun 64 (1996) 2609-2617
18. Djeu J.Y., Matsushima K., Oppenheim J.J., Shiotsuki K., and Blanchard D.K. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 144 (1990) 2205-2210
19. Nicolatou-Galitis O., Dardoufas K., Markoulatos P., Sotiropoulou-Lontou A., Kyprianou K., Kolitsi G., et al. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor [GM-CSF] mouthwash. J Oral Pathol Med 30 (2001) 471-480
20. Vazquez J.A., Gupta S., and Villanueva A. Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients. Eur J Clin Microbiol Infect Dis 17 (1998) 781-783
21. Kupper T.S. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 94 (1990) 146S-150S
22. Wang M., Friedman H., and Djeu J.Y. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors [CSF]: IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol 14 (1989) 671-677
23. Noverr M.C., Phare S.M., Toews G.B., Coffey M.J., and Huffnagle G.B. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69 (2001) 2957-2963
24. Castro M., Ralston N.V., Morgenthaler T.I., Rohrbach M.S., and Limper A.H. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect Immun 62 (1994) 3138-3145
25. Clarke D.L., Belvisi M.G., Catley M.C., Yacoub M.H., Newton R., and Giembycz M.A. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. Br J Pharmacol 141 (2004) 1141-1150
26. Gewirtz A.T., Collier-Hyams L.S., Young A.N., Kucharzik T., Guilford W.J., Parkinson J.F., et al. Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 168 (2002) 5260-5267
27. Samaranayake L.P., Raeside J.M., and MacFarlane T.W. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22 (1984) 201-207
28. Collin B., Clancy C.J., and Nguyen M.H. Antifungal resistance in non-albicans Candida species. Drug Resist Updat 2 (1999) 9-14
29. Kantarcioglu A.S., and Yucel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 45 (2002) 160-165
30. Yamamoto T., Nohara K., Uchida K., and Yamaguchi H. Purification and characterization of secretory proteinase of Candida albicans. Microbiol Immunol 36 (1992) 637-641
31. El-Azizi M.A., Starks S.E., and Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol 96 (2004) 1067-1073
32. Helmerhorst E.J., Venuleo C., Beri A., and Oppenheim F.G. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast 22 (2005) 705-714
33. Feng Z., Jiang B., Chandra J., Ghannoum M., Nelson S., and Weinberg A. Human beta-defensins: differential activity against Candida species and regulation by Candida albicans. J Dent Res 84 (2005) 445-450
34. Joly S., Maze C., McCray Jr. P.B., and Guthmiller J.M. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42 (2004) 1024-1029
35. Cormack B.P., Ghori N., and Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 23 (1999) 578-582
36. Kamran M., Calcagno A.M., Findon H., Bignell E., Jones M.D., Warn P., et al. Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence. Eukaryot Cell 2 (2004) 546-552
37. Gillum A.M., Tsay E.Y., and Kirsch D.R. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198 (1984) 179-182
38. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J Y., Weinberg R.A., et al. Human keratinocytes that express hTERT and also bypass a p16 INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20 (2000) 1436-1447
39. Feucht E.C., DeSanti C.L., and Weinberg A. Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol Immunol 18 (2003) 359-363